Advances in Type 1 Diabetes Ocular Remote Tele-Health Screening

Crossmark: check for updates

Authors

  • Loka Thangamathesvaran Institute of Ophthalmology and Visual Science, New Jersey Medical School, Rutgers University, Newark, NJ, USA
  • Christopher Khouri Institute of Ophthalmology and Visual Science, New Jersey Medical School, Rutgers University, Newark, NJ, USA
  • Liliane Deeb Institute of Ophthalmology and Visual Science, New Jersey Medical School, Rutgers University, Newark, NJ, USA
  • Ben C. Szirth Institute of Ophthalmology and Visual Science, New Jersey Medical School, Rutgers University, Newark, NJ, USA
  • Albert S. Khouri Institute of Ophthalmology and Visual Science, New Jersey Medical School, Rutgers University, Newark, NJ, USA

DOI:

https://doi.org/10.17140/DROJ-3-135

Keywords:

Retinopathy Type 1 Diabetes, Diabetic retinopathy Retinal screenings, Non mydriatic retinal camera, Ocular coherence tomography (OCT) OCT-A

Abstract

Background: Type 1 diabetes affects approximately 3 million Americans. Subjects are on average 14-years-old at time of diagnosis. It is a systemic, chronic condition that has retinal complications. Yearly ophthalmic consultation is important to maintaining adequate ocular health. The National Institute of Health (NIH) estimates that about half of individuals affected by diabetes are not aware they have some level of retinopathy.1 The goal of community base remote screenings is to identify at risk individuals and refer them for comprehensive clinical evaluation and possible intervention. Methods: Retinal screenings were conducted in July 2016 in conjunction with annual Friends for Life convention organized by Children with Diabetes (http://www.childrenwithdiabetes. com). In total, 218 participants were included in a comprehensive retinal screening. Self-reported baseline measurements of body mass index (BMI), blood pressure (BP), visual acuity and pupil size were recorded. An auto-refractor (Canon, Tokyo, Japan) and automated puff tonometer (Canon, Tokyo, Japan) were used to note visual acuity and intraocular pressure (IOP). Imaging modalities used to assess ocular health included a spectral domain ocular coherence tomography (OCT) (Optovue, iVue, Fremont, California, USA), ocular coherence tomographyangiography (Optovue, iVue, Fremont, California, USA), and a non-mydriatic retinal camera (Canon, Tokyo, Japan). Results: Our ocular screening included 218 participants, 61%female and 39% male. Ages ranged from 4 to 73 with an average of 19±12.8 years. The average blood pressure was 111/70. HbA1C ranged from 5.1 to 13.0 with an average of 7.6±1.16. Average duration of diabetes for all subjects was 10 years. Most subjects on average had been using insulin pumps and continuous glucose monitoring devices (CGM) for 7 and 3.5 years respectively. Of the 218 subjects ten had dot hemorrhages, three had flame hemorrhages and one had intraretinal microvascular abnormalities (IRMAs) affecting at least one eye. One subject required emergency referral to medical retina while 15 were referred for anterior segment evaluation for nuclear sclerosis. Conclusions: Comprehensive remote screenings including OCT, OCT-A and non-mydriatic retinal evaluation can provide a quick, efficient way to assess ocular health in T1DM. Yearly ophthalmic consultation can help detect retinal health at an early stage and better implement lifestyle modifications to minimize further complications.

References

Cavan D. The diabetes epidemic and its implications for eye health. Community Eye Health. 2015; 28(92): 61-63.

Miller RG, Secrest AM, Sharma RK, Songer TJ, Orchard TJ. Improvements in the life expectancy of type 1 diabetes: The pittsburgh epidemiology of diabetes complications study cohort. diabetes. 2012; 61(11): 2987-2992. doi: 10.2337/db11-1625

Veerendranath P, Donovan L, Taneja M, et al. Measurement of consensual accommodation in vision-impaired eyes. Op-tom Vis Sci. 2014; 91(7): 752-759. doi: 10.1097/OPX.00000 00000000294

Pimentel LGM, Gracitelli CPB, da Silva LS, et al. Association between glucose levels and intraocular pressure: Pre- and post-prandial analysis in diabetic and nondiabetic patients. J Oph-thalmol. 2015; 2015: 5. doi: 10.1155/2015/832058

Helmy YM, Allah HRA. Optical coherence tomography clas-sification of diabetic cystoid macular edema. Clin Ophthalmol. 2013; 7: 1731-1737. doi: 10.2147/OPTH.S47987

Chen JT. Optical coherence tomography angiography, the powerful new imaging modality for clinical ophthalmology. Taiwan J Ophthalmol. 2017; 7(3): 113-114. doi: 10.4103/2211- 5056.214233

Wu L MN, Padgaonkar P, Kommana S, Wu E, Szirth B, Khou-ri A. Type 1 diabetic and hypertensive retinopathy: Case presen-tation and review of literature. Diabetes Res Open J. 2015; 1(4): 113-122. doi: 10.17140/DROJ-1-118

Published

2017-11-07

How to Cite

Loka Thangamathesvaran, Christopher Khouri, Liliane Deeb, Ben C. Szirth, & Albert S. Khouri. (2017). Advances in Type 1 Diabetes Ocular Remote Tele-Health Screening. Diabetes Research, 3(2), 42–47. https://doi.org/10.17140/DROJ-3-135

Most read articles by the same author(s)